Investor update presentation for Medical Facilities Corporation following their announcing fourth quarter and year end results for 2019. Medical Facilities Corporation's common shares are listed on the TSX under the symbol DR.
Centric Health Corporation - Investor Presentation - April 2, 2020Trevor Heisler
Centric Health is an essential service provider and one of Canada's leading providers of Specialty Pharmacy services to seniors in long-term care and retirement homes.
Ceres Global Ag 2021 AGM management presentationSharePitch
Management presentation from the annual shareholders meeting of Ceres Global Ag Corp (TSX: CRP). Includes an update on the Corporation's plans to build a $350 million canola crush plant.
Centric Health Corporation - 2020 Annual Meeting - Management PresentationSharePitch
Management presentation slides from the June 18, 2020 annual and special meeting of shareholders. The presentation provides an overview of Centric Health Corporation following its recent acquisition of Remedy’sRx Specialty Pharmacy, and highlights recent milestones and strategies for future growth.
Updated investor presentation for Flower One Holdings. The Company’s common shares are traded on the Canadian Securities Exchange under the Company’s symbol "FONE", in the United States on the OTCQX Best Market under the symbol "FLOOF" and on the Frankfurt Stock Exchange under the symbol “F11”. For more information, visit: https://flowerone.com.
Centric Health Corporation - Investor Presentation - May 2020SharePitch
Updated investor presentation for Centric Health Corporation (TSX: CHH). Updates include the competion of the Remedy'sRx acquisition and first quarter financial results.
Medical Facilities Corporation - 2021 Annual MeetingSharePitch
Slides accompanying the management presentation delivered by the CEO and CFO of Medical Facilities Corporation during their 2021 annual shareholders meeting on May 13, 2021.
Medical Facilities Corporation - 2020 Annual Shareholder Meeting PresentationSharePitch
Slides for the management presentation delivered during Medical Facilities Corporation's 2020 annual general meeting of shareholders. Medical Facilities Corporation (“MFC”), in partnership with physicians, owns surgical facilities in the United States.
Centric Health Corporation - Investor Presentation - April 2, 2020Trevor Heisler
Centric Health is an essential service provider and one of Canada's leading providers of Specialty Pharmacy services to seniors in long-term care and retirement homes.
Ceres Global Ag 2021 AGM management presentationSharePitch
Management presentation from the annual shareholders meeting of Ceres Global Ag Corp (TSX: CRP). Includes an update on the Corporation's plans to build a $350 million canola crush plant.
Centric Health Corporation - 2020 Annual Meeting - Management PresentationSharePitch
Management presentation slides from the June 18, 2020 annual and special meeting of shareholders. The presentation provides an overview of Centric Health Corporation following its recent acquisition of Remedy’sRx Specialty Pharmacy, and highlights recent milestones and strategies for future growth.
Updated investor presentation for Flower One Holdings. The Company’s common shares are traded on the Canadian Securities Exchange under the Company’s symbol "FONE", in the United States on the OTCQX Best Market under the symbol "FLOOF" and on the Frankfurt Stock Exchange under the symbol “F11”. For more information, visit: https://flowerone.com.
Centric Health Corporation - Investor Presentation - May 2020SharePitch
Updated investor presentation for Centric Health Corporation (TSX: CHH). Updates include the competion of the Remedy'sRx acquisition and first quarter financial results.
Medical Facilities Corporation - 2021 Annual MeetingSharePitch
Slides accompanying the management presentation delivered by the CEO and CFO of Medical Facilities Corporation during their 2021 annual shareholders meeting on May 13, 2021.
Medical Facilities Corporation - 2020 Annual Shareholder Meeting PresentationSharePitch
Slides for the management presentation delivered during Medical Facilities Corporation's 2020 annual general meeting of shareholders. Medical Facilities Corporation (“MFC”), in partnership with physicians, owns surgical facilities in the United States.
HOUSTON, TX and ROSEMONT, IL – December 9, 2013 – Sysco Corporation [NYSE: SYY] and US Foods today announced an agreement to merge, creating a world-class foodservice company. The total enterprise value of the transaction is approximately $8.2 billion and the combination has been approved by the Board of Directors of each company.
This document provides an agenda for a Cardinal Health, Inc. Dublin Day event on June 1, 2017. The agenda includes opening remarks by company leadership, presentations on the Specialty Solutions and Pharmaceutical segments, and Q&A sessions. It also discusses Cardinal Health's role in the growing specialty pharmaceutical industry, including its end-to-end solutions across the product lifecycle and extensive provider distribution footprint. Finally, it outlines how Cardinal Health is well-positioned to help manufacturers, providers and patients in the biosimilars market through regulatory, marketing, distribution, analytics and patient support services.
Document Security Systems (DSS) is a multinational company operating businesses focused
on brand protection technology, blockchain security, direct marketing, healthcare, real estate,
and securitized digital assets. Its business model is based on a distribution sharing system in
which shareholders will receive shares in its subsidiaries as DSS strategically spins them out
into IPOs. Its historic business revolves around counterfeit deterrent and authentication
technologies, smart packaging, and consumer product engagement. DSS is led by its seasoned
leaders with decades of industry experience.
DSS Inc. (NYSE American: DSS) is a multinational company operating business segments in blockchain security, direct marketing, healthcare, consumer packaging, real estate, renewable energy, and securitized digital assets. Its business model is based on a distribution sharing system in which shareholders will receive shares in its subsidiaries as DSS strategically spins them out into IPOs. DSS is led by its seasoned leaders with decades of industry experience.
- Pfizer reported financial results for the third quarter of 2017, with revenues of $13.2 billion, up 1% from the third quarter of 2016. Net income was $2.8 billion, up 110% from the prior year.
- The company narrowed its full-year 2017 revenue guidance range to between $52.4-53.1 billion and raised the midpoint of its adjusted diluted EPS guidance range to $2.60.
- Pfizer highlighted several recent product and pipeline milestones, including positive data readouts for Xtandi and its biosimilar trastuzumab candidate as well as regulatory approvals for Bavencio, Besponsa and Mylotarg.
Diplomat is a specialty pharmacy company that has experienced strong growth through expansion into new therapeutic areas and services. It focuses on specialty drugs like oncology that require complex care management. Diplomat has a unique limited distribution model that gives it exclusive access to certain specialty drugs, fueling its ability to gain market share. The company plans to continue its growth strategy through organic growth, acquisitions, and expanding relationships with drug manufacturers and payors.
Medicine Man Technologies provides cannabis consulting services and products to cannabis growers nationwide and internationally. Their services include consulting, cultivation optimization through their Cultivation Max program, and cannabis nutrients sold under the Success Nutrients brand. Medicine Man has acquired companies to expand their product and service offerings and pursue a strategy of building a "cannabis brand warehouse". They have experienced rapid revenue growth in recent years and expect new acquisitions and cross-selling opportunities to further drive sustainable revenue growth.
Better Choice Company (OTCQB: BTTR) is a rapidly growing animal health and wellness company committed to leading the industry shift toward pet products and services that help dogs and cats live healthier, happier and longer lives. Better Choice takes an alternative, nutrition-based approach to animal health relative to conventional dog and cat food offerings, and positions its portfolio of brands to benefit from the mainstream trends of growing pet humanization and consumer focus on health and wellness. The Company has a demonstrated, multi-decade track record of success selling trusted animal health and wellness products, and leverage its established digital footprint to provide pet parents with the knowledge to make informed decisions about their pet’s health. Better Choice sells the majority of its dog food, cat food and treats under the Halo and TruDog brands, which are focused, respectively, on providing sustainably sourced kibble and canned food derived from real whole meat, and minimally processed raw-diet dog food and treats.
Cardinal Health reported financial results for Q3 FY2017 with total revenue of $31.8 billion, up 4% from the previous year. Operating earnings were $605 million, down 8% due to generic drug pricing pressures and investments in IT systems. The outlook for FY2017 expects revenue to increase in the mid-to-high single digit percentage range with non-GAAP diluted EPS expected between $5.24-$5.50. Key assumptions include continued generic drug price deflation, brand drug price inflation, and contributions from acquisitions offset by lower benefits from generic launches and Red Oak Sourcing.
Better Choice Company (OTCQB: BTTR) is a rapidly growing animal health and wellness company committed to leading the industry shift toward pet products and services that help dogs and cats live healthier, happier and longer lives. Better Choice takes an alternative, nutrition-based approach to animal health relative to conventional dog and cat food offerings, and positions its portfolio of brands to benefit from the mainstream trends of growing pet humanization and consumer focus on health and wellness. The Company has a demonstrated, multi-decade track record of success selling trusted animal health and wellness products, and leverage its established digital footprint to provide pet parents with the knowledge to make informed decisions about their pet’s health. Better Choice sells the majority of its dog food, cat food and treats under the Halo and TruDog brands, which are focused, respectively, on providing sustainably sourced kibble and canned food derived from real whole meat, and minimally processed raw-diet dog food and treats.
The document is an investor presentation for Flower One Holdings Inc. that provides an overview of the company, its flagship cannabis cultivation and production facility in Nevada, financial performance, leadership team, and growth strategy. Key points include Flower One operating the largest greenhouse facility in Nevada with potential annual production capacity of over 100,000 pounds, generating increasing quarterly revenues, restructuring to reduce debt and costs, and an experienced new leadership team to execute on strategic expansion plans.
This document contains forward-looking statements about Cardiff International, Inc. It summarizes that Cardiff is a holding company that provides private companies an exit strategy and equity capitalization platform through mergers, acquisitions, and holding subsidiaries. It aims to become a "mini Berkshire Hathaway" for smaller companies. The document outlines Cardiff's current subsidiaries, management team, acquisition process, investors, and future outlook. It positions Cardiff for over $20 million in revenue in 2017 and outlines its strategy to reach $100 million in market cap by year's end.
This company presentation contains forward-looking statements and discusses the risks associated with those statements. It provides an overview of the company, including its size, growth rate, clients, revenues, competitive advantages, and leadership team. The document discusses the company's data collection and analytics platforms, products and services, growth strategy, and financial highlights including recurring revenue, margins, and balance sheet strength.
Aveda energy investor presentation september 2013AvedaEnergy
This investor presentation provides an overview of Aveda Transportation and Energy Services, a growing provider of specialized oilfield hauling and rentals in Western Canada and the US. The summary highlights Aveda's experienced management team, financial performance showing consecutive quarters of revenue growth, and growth strategy focused on organic expansion and acquisitions to capitalize on opportunities in key North American oil and gas plays.
Aurora investor presentation acquisition of canni-med therapeuticsMarc Lakmaaker
- Aurora has acquired CanniMed Therapeutics to form a medical cannabis centre of excellence and gain CanniMed's drug delivery technologies and strong brands.
- The acquisition adds 19,000 kg per year of funded production capacity and expands Aurora's international footprint.
- The combination of Aurora and CanniMed enhances Aurora's medical offerings with CanniMed's four balanced ratio cannabis strains.
- Pfizer reported its second quarter 2017 earnings results, with revenues of $12.9 billion, a 2% decrease from the second quarter of 2016. Net income increased 50% to $3.1 billion compared to the prior year.
- Several of Pfizer's key drugs performed strongly in the quarter, including Ibrance, Eliquis, and Xeljanz. The company also achieved regulatory approvals for new drugs and indications.
- Pfizer raised its guidance for 2017 adjusted diluted EPS to a range of $2.54 to $2.60 per share, up from its previous range of $2.50 to $2.60. The company reaffirmed the rest of its 2017 financial
- QTS Realty Trust reported financial results for the first quarter of 2021, with adjusted EBITDA of $82 million, operating FFO per share of $0.76, and revenue of $149 million.
- Leasing activity was strong in Q1, with $21 million in new and modified lease signings. Backlog of signed but not commenced leases was $81 million in annualized GAAP rent.
- Guidance for full year 2021 was reiterated, with revenue expected to be $606 million at the midpoint and adjusted EBITDA expected to be $336.5 million at the midpoint.
Thor Industries is one of the world's largest manufacturers of RVs. It has over 8,300 employees and 107 facilities across 4 US states. The document discusses Thor's product range, competitive advantages, and positive outlook for the RV industry. Wholesale shipments and retail registrations have rebounded in recent years, and dealer inventories are at appropriate levels to meet continuing consumer demand.
The document provides an overview of Brink's, a global secure logistics company, ahead of investor meetings in August 2017. It discusses Brink's leadership position in the cash management market, growth strategy focused on profitable growth, operational excellence and introducing differentiated services, and strategic execution through organic initiatives and acquisitions. Brink's targets revenue of $3.3 billion and operating profit margin of 12.5% by 2019 through this strategy. Recent acquisitions are expected to contribute $175 million in additional revenue and $45 million in operating profit to the 2019 targets.
This document provides a summary of a financial analysis of Pfizer conducted by Riley Bannon and Dylan Murphy. It includes an executive summary, purpose, methodology, economic analysis, industry forecast, analysis of Pfizer's competition and business, and conclusions and recommendations. The economic analysis forecasts modest GDP growth of around 2.8% annually through 2018, a declining unemployment rate, and gradual interest rate increases. The industry forecast expects continued strong demand for pharmaceuticals driven by an aging population, though tempered growth due to potential increased regulation. The document analyzes Pfizer's financials, business strategy, valuation, and competition to make an investment recommendation.
Medical Facilities Corporation - Investor Presentation - October 2020SharePitch
New investor presentation from Medical Facilities Corp. (TSX: DR), updated with first half 2020 results. Medical Facilities Corporation, in partnership with physicians, owns a diverse portfolio of highly rated, high-quality surgical facilities in the United States. For more information, please visit www.medicalfacilitiescorp.ca.
Medical Facilities Corporation - 2020 Annual ReportSharePitch
Medical Facilities Corporation ("MFC") is strategically positioned to capitalize on strong market fundamentals and growth opportunities. MFC is listed on the TSX under the symbol 'DR.'
HOUSTON, TX and ROSEMONT, IL – December 9, 2013 – Sysco Corporation [NYSE: SYY] and US Foods today announced an agreement to merge, creating a world-class foodservice company. The total enterprise value of the transaction is approximately $8.2 billion and the combination has been approved by the Board of Directors of each company.
This document provides an agenda for a Cardinal Health, Inc. Dublin Day event on June 1, 2017. The agenda includes opening remarks by company leadership, presentations on the Specialty Solutions and Pharmaceutical segments, and Q&A sessions. It also discusses Cardinal Health's role in the growing specialty pharmaceutical industry, including its end-to-end solutions across the product lifecycle and extensive provider distribution footprint. Finally, it outlines how Cardinal Health is well-positioned to help manufacturers, providers and patients in the biosimilars market through regulatory, marketing, distribution, analytics and patient support services.
Document Security Systems (DSS) is a multinational company operating businesses focused
on brand protection technology, blockchain security, direct marketing, healthcare, real estate,
and securitized digital assets. Its business model is based on a distribution sharing system in
which shareholders will receive shares in its subsidiaries as DSS strategically spins them out
into IPOs. Its historic business revolves around counterfeit deterrent and authentication
technologies, smart packaging, and consumer product engagement. DSS is led by its seasoned
leaders with decades of industry experience.
DSS Inc. (NYSE American: DSS) is a multinational company operating business segments in blockchain security, direct marketing, healthcare, consumer packaging, real estate, renewable energy, and securitized digital assets. Its business model is based on a distribution sharing system in which shareholders will receive shares in its subsidiaries as DSS strategically spins them out into IPOs. DSS is led by its seasoned leaders with decades of industry experience.
- Pfizer reported financial results for the third quarter of 2017, with revenues of $13.2 billion, up 1% from the third quarter of 2016. Net income was $2.8 billion, up 110% from the prior year.
- The company narrowed its full-year 2017 revenue guidance range to between $52.4-53.1 billion and raised the midpoint of its adjusted diluted EPS guidance range to $2.60.
- Pfizer highlighted several recent product and pipeline milestones, including positive data readouts for Xtandi and its biosimilar trastuzumab candidate as well as regulatory approvals for Bavencio, Besponsa and Mylotarg.
Diplomat is a specialty pharmacy company that has experienced strong growth through expansion into new therapeutic areas and services. It focuses on specialty drugs like oncology that require complex care management. Diplomat has a unique limited distribution model that gives it exclusive access to certain specialty drugs, fueling its ability to gain market share. The company plans to continue its growth strategy through organic growth, acquisitions, and expanding relationships with drug manufacturers and payors.
Medicine Man Technologies provides cannabis consulting services and products to cannabis growers nationwide and internationally. Their services include consulting, cultivation optimization through their Cultivation Max program, and cannabis nutrients sold under the Success Nutrients brand. Medicine Man has acquired companies to expand their product and service offerings and pursue a strategy of building a "cannabis brand warehouse". They have experienced rapid revenue growth in recent years and expect new acquisitions and cross-selling opportunities to further drive sustainable revenue growth.
Better Choice Company (OTCQB: BTTR) is a rapidly growing animal health and wellness company committed to leading the industry shift toward pet products and services that help dogs and cats live healthier, happier and longer lives. Better Choice takes an alternative, nutrition-based approach to animal health relative to conventional dog and cat food offerings, and positions its portfolio of brands to benefit from the mainstream trends of growing pet humanization and consumer focus on health and wellness. The Company has a demonstrated, multi-decade track record of success selling trusted animal health and wellness products, and leverage its established digital footprint to provide pet parents with the knowledge to make informed decisions about their pet’s health. Better Choice sells the majority of its dog food, cat food and treats under the Halo and TruDog brands, which are focused, respectively, on providing sustainably sourced kibble and canned food derived from real whole meat, and minimally processed raw-diet dog food and treats.
Cardinal Health reported financial results for Q3 FY2017 with total revenue of $31.8 billion, up 4% from the previous year. Operating earnings were $605 million, down 8% due to generic drug pricing pressures and investments in IT systems. The outlook for FY2017 expects revenue to increase in the mid-to-high single digit percentage range with non-GAAP diluted EPS expected between $5.24-$5.50. Key assumptions include continued generic drug price deflation, brand drug price inflation, and contributions from acquisitions offset by lower benefits from generic launches and Red Oak Sourcing.
Better Choice Company (OTCQB: BTTR) is a rapidly growing animal health and wellness company committed to leading the industry shift toward pet products and services that help dogs and cats live healthier, happier and longer lives. Better Choice takes an alternative, nutrition-based approach to animal health relative to conventional dog and cat food offerings, and positions its portfolio of brands to benefit from the mainstream trends of growing pet humanization and consumer focus on health and wellness. The Company has a demonstrated, multi-decade track record of success selling trusted animal health and wellness products, and leverage its established digital footprint to provide pet parents with the knowledge to make informed decisions about their pet’s health. Better Choice sells the majority of its dog food, cat food and treats under the Halo and TruDog brands, which are focused, respectively, on providing sustainably sourced kibble and canned food derived from real whole meat, and minimally processed raw-diet dog food and treats.
The document is an investor presentation for Flower One Holdings Inc. that provides an overview of the company, its flagship cannabis cultivation and production facility in Nevada, financial performance, leadership team, and growth strategy. Key points include Flower One operating the largest greenhouse facility in Nevada with potential annual production capacity of over 100,000 pounds, generating increasing quarterly revenues, restructuring to reduce debt and costs, and an experienced new leadership team to execute on strategic expansion plans.
This document contains forward-looking statements about Cardiff International, Inc. It summarizes that Cardiff is a holding company that provides private companies an exit strategy and equity capitalization platform through mergers, acquisitions, and holding subsidiaries. It aims to become a "mini Berkshire Hathaway" for smaller companies. The document outlines Cardiff's current subsidiaries, management team, acquisition process, investors, and future outlook. It positions Cardiff for over $20 million in revenue in 2017 and outlines its strategy to reach $100 million in market cap by year's end.
This company presentation contains forward-looking statements and discusses the risks associated with those statements. It provides an overview of the company, including its size, growth rate, clients, revenues, competitive advantages, and leadership team. The document discusses the company's data collection and analytics platforms, products and services, growth strategy, and financial highlights including recurring revenue, margins, and balance sheet strength.
Aveda energy investor presentation september 2013AvedaEnergy
This investor presentation provides an overview of Aveda Transportation and Energy Services, a growing provider of specialized oilfield hauling and rentals in Western Canada and the US. The summary highlights Aveda's experienced management team, financial performance showing consecutive quarters of revenue growth, and growth strategy focused on organic expansion and acquisitions to capitalize on opportunities in key North American oil and gas plays.
Aurora investor presentation acquisition of canni-med therapeuticsMarc Lakmaaker
- Aurora has acquired CanniMed Therapeutics to form a medical cannabis centre of excellence and gain CanniMed's drug delivery technologies and strong brands.
- The acquisition adds 19,000 kg per year of funded production capacity and expands Aurora's international footprint.
- The combination of Aurora and CanniMed enhances Aurora's medical offerings with CanniMed's four balanced ratio cannabis strains.
- Pfizer reported its second quarter 2017 earnings results, with revenues of $12.9 billion, a 2% decrease from the second quarter of 2016. Net income increased 50% to $3.1 billion compared to the prior year.
- Several of Pfizer's key drugs performed strongly in the quarter, including Ibrance, Eliquis, and Xeljanz. The company also achieved regulatory approvals for new drugs and indications.
- Pfizer raised its guidance for 2017 adjusted diluted EPS to a range of $2.54 to $2.60 per share, up from its previous range of $2.50 to $2.60. The company reaffirmed the rest of its 2017 financial
- QTS Realty Trust reported financial results for the first quarter of 2021, with adjusted EBITDA of $82 million, operating FFO per share of $0.76, and revenue of $149 million.
- Leasing activity was strong in Q1, with $21 million in new and modified lease signings. Backlog of signed but not commenced leases was $81 million in annualized GAAP rent.
- Guidance for full year 2021 was reiterated, with revenue expected to be $606 million at the midpoint and adjusted EBITDA expected to be $336.5 million at the midpoint.
Thor Industries is one of the world's largest manufacturers of RVs. It has over 8,300 employees and 107 facilities across 4 US states. The document discusses Thor's product range, competitive advantages, and positive outlook for the RV industry. Wholesale shipments and retail registrations have rebounded in recent years, and dealer inventories are at appropriate levels to meet continuing consumer demand.
The document provides an overview of Brink's, a global secure logistics company, ahead of investor meetings in August 2017. It discusses Brink's leadership position in the cash management market, growth strategy focused on profitable growth, operational excellence and introducing differentiated services, and strategic execution through organic initiatives and acquisitions. Brink's targets revenue of $3.3 billion and operating profit margin of 12.5% by 2019 through this strategy. Recent acquisitions are expected to contribute $175 million in additional revenue and $45 million in operating profit to the 2019 targets.
This document provides a summary of a financial analysis of Pfizer conducted by Riley Bannon and Dylan Murphy. It includes an executive summary, purpose, methodology, economic analysis, industry forecast, analysis of Pfizer's competition and business, and conclusions and recommendations. The economic analysis forecasts modest GDP growth of around 2.8% annually through 2018, a declining unemployment rate, and gradual interest rate increases. The industry forecast expects continued strong demand for pharmaceuticals driven by an aging population, though tempered growth due to potential increased regulation. The document analyzes Pfizer's financials, business strategy, valuation, and competition to make an investment recommendation.
Medical Facilities Corporation - Investor Presentation - October 2020SharePitch
New investor presentation from Medical Facilities Corp. (TSX: DR), updated with first half 2020 results. Medical Facilities Corporation, in partnership with physicians, owns a diverse portfolio of highly rated, high-quality surgical facilities in the United States. For more information, please visit www.medicalfacilitiescorp.ca.
Medical Facilities Corporation - 2020 Annual ReportSharePitch
Medical Facilities Corporation ("MFC") is strategically positioned to capitalize on strong market fundamentals and growth opportunities. MFC is listed on the TSX under the symbol 'DR.'
Mercer Capital's Value Focus: Medical Technology | Q2 2022Mercer Capital
The document provides a summary of a quarterly report from Mercer Capital on the medtech and device industry for Q2 2022. It includes a review of market performance, valuation multiples, operating metrics, M&A activity, and IPOs during Q1 2022. It also discusses Mercer Capital's experience providing valuation services to companies in the sector. The summary focuses on key trends in the industry including demographic shifts driving demand, healthcare spending growth in the US, the impact of third-party reimbursement, competitive factors, and regulatory environment.
Financial Planning In Healthcare PowerPoint Presentation Slides SlideTeam
This complete deck is oriented to make sure you do not lag in your presentations. Our creatively crafted slides come with apt research and planning. This exclusive deck with fourtythree slides is here to help you to strategize, plan, analyse, or segment the topic with clear understanding and apprehension. Utilize ready to use presentation slides on Financial Planning In Healthcare PowerPoint Presentation Slides with all sorts of editable templates, charts and graphs, overviews, analysis templates. It is usable for marking important decisions and covering critical issues. Display and present all possible kinds of underlying nuances, progress factors for an all inclusive presentation for the teams. This presentation deck can be used by all professionals, managers, individuals, internal external teams involved in any company organization.
Mercer Capital's Value Focus: Medical Technology | Mid-Year 2021Mercer Capital
Mercer Capital's Medical Technology Industry newsletter provides perspective on valuation issues. Each newsletter also includes macroeconomic trends, public market trends, and comparable public company metrics.
Mercer Capital's Value Focus: Medtech & Device Industry | Q3 2019 | Article: ...Mercer Capital
This document provides an overview and market analysis of the medical device industry. It discusses key trends influencing demand, including an aging global population driving higher healthcare spending. Regulatory and reimbursement landscapes play a large role in device adoption and pricing. The transition to value-based care may lead to lower procedure volumes and reimbursement rates. Medical device companies face competitive pressures to continuously innovate and obtain necessary regulatory clearances for new products.
Monetary Administration In Healthcare PowerPoint Presentation Slides SlideTeam
Presenting this set of slides with name - Monetary Administration In Healthcare Powerpoint Presentation Slides. This deck consists of total of fourty slides. It has PPT slides highlighting important topics of Monetary Administration In Healthcare Powerpoint Presentation Slides. This deck comprises of amazing visuals with thoroughly researched content. Each template is well crafted and designed by our PowerPoint experts. Our designers have included all the necessary PowerPoint layouts in this deck. From icons to graphs, this PPT deck has it all. The best part is that these templates are easily customizable. Just click the DOWNLOAD button shown below. Edit the colour, text, font size, add or delete the content as per the requirement. Download this deck now and engage your audience with this ready made presentation.
The document is an investor presentation for Hanger, Inc. that discusses the company's orthotics and prosthetics business. It provides an overview of the company, the orthotics and prosthetics market, and Hanger's two business segments - Patient Care and Products & Services.
The key points are:
1) Hanger is the leading provider of orthotic and prosthetic services in the US, with over 800 clinic locations nationwide.
2) The orthotics and prosthetics market is sizable at $4.3 billion annually and is growing due to injuries and diseases that drive demand.
3) Hanger's Patient Care segment makes up the majority of its business, generating 82.5% of
NeoGenomics Company Overview highlights. It includes investment highlights, Consistent historical growth charts, accelerating cash flow & earnings, management team, testing services, customer targets, formula for success, industry dynamics, U.S. cancer market size, cancer testing market characteristics, key growth drivers...
Canada's healthcare claims management market is likely to grow at a CAGR of 23.4% from a market size of $2.13 Bn in 2022 to $11.48 Bn in 2030. The rise in research and development expenditure in healthcare along with the new technological advancements and the increasing trend of automation in healthcare acts as a growth factor for the market. To get a detailed report, contact us at - info@insights10.com
Mercer Capital's Value Focus: Healthcare Facilities | Mid-Year 2014Mercer Capital
Mercer Capital's Healthcare Facilities Industry newsletter provides perspective on valuation issues. Each newsletter also includes a macroeconomic trends, industry trends, and guideline public company metrics.
Agility health investor presentation - investor tab 07.18.16AgilityHealth
Agility Health is a leading healthcare provider focused on physical rehabilitation services. It operates over 155 locations across the US. The presentation provides an overview of Agility Health's business model, growth strategy, and financial performance. It aims to capitalize on the large and fragmented physical rehabilitation industry through acquisitions, organic growth, and its proprietary software system. Key highlights include double-digit revenue and EBITDA growth in recent quarters and an experienced management team.
The document discusses Quality Systems, Inc. and its NextGen Healthcare subsidiary which develop and provide computer-based business applications for medical and dental group practices. It provides an overview of the company's financial performance, competitive advantages, product offerings, growth strategy, and outlook given positive healthcare industry trends and economic stimulus activities. The company has a proven track record of growth and profitability with a large, recurring customer base and leading software solutions.
NeoGenomics overview presetnation ontains statements which constitute forward-looking statements within the meaning of Section 27A of the Securities Act, as amended; Section 21E of the Securities Exchange Act of 1934; and the Private Securities Litigation Reform Act of 1995. The words “may”, “would”, “could”, “will”, “expect”, “estimate”, “anticipate”, “believe”, “intend”, “plan”, “goal”, and similar expressions and variations thereof are intended to specifically identify forward-looking statements. All statements that are not statements of historical fact are forward-looking statements.
This presentation contains statements which constitute forward-looking statements within the meaning of Section 27A of the Securities Act, as amended; Section 21E of the Securities Exchange Act of 1934; and the Private Securities Litigation Reform Act of 1995. The words “may”, “would”, “could”, “will”, “expect”, “estimate”, “anticipate”, “believe”, “intend”, “plan”, “goal”, and similar expressions and variations thereof are intended to specifically identify forward-looking statements. All statements that are not statements of historical fact are forward-looking statements.
Investors and prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. The risks that might cause such differences are identified in our filings with the Securities and Exchange Commission. We undertake no obligation to publicly update or revise the forward looking statements made in this presentation to reflect events or circumstances after
Tenet Healthcare's CEO presented at the J.P. Morgan Healthcare Conference on January 11, 2022. Over the past several years, Tenet has transformed its portfolio, restructured operations, and improved quality and safety outcomes. It has demonstrated resiliency during the COVID-19 pandemic by consistently meeting or beating quarterly earnings guidance. Tenet aims to continue this growth trajectory by enhancing specialty care access, scaling its ambulatory surgery platform, and leading new high acuity services in lower cost settings.
Commercial Management In Healthcare PowerPoint Presentation Slides SlideTeam
This PPT deck displays fourtytwo slides with in depth research. Our topic oriented Commercial Management In Healthcare PowerPoint Presentation Slides presentation deck is a helpful tool to plan, prepare, document and analyse the topic with a clear approach. We provide a ready to use deck with all sorts of relevant topics subtopics templates, charts and graphs, overviews, analysis templates. Outline all the important aspects without any hassle. It showcases of all kind of editable templates infographs for an inclusive and comprehensive Commercial Management In Healthcare PowerPoint Presentation Slides presentation. Professionals, managers, individual and team involved in any company organization from any field can use them as per requirement.
Healthcare Payer Services Market Research Report, 2024 | Grand View Research ...Uday M
Healthcare Payer Services Market Analysis By Outsourcing Services (BPO, ITO, KPO), By Application (Claims Management Services, Integrated Front Office Service And Back Office Operations, Member Management Services, Provider Management Services, Billing And Accounts Management Services, Analytics And Fraud Management Services, HR Services), By End Use (Private Payers, Public Payers), And Segment Forecasts To 2024
NeoGenomics Forward-looking statements, Investment Highlights, Consistent Historical Growth, Accelerating Cash FLow & Earnings, Management Team, Cancer Testing Services, Customer Targets, NeoGenomics Formula for Success, Industry Dynamics, US Cancer Testing Market Size, Cancer Testing Market Characteristics, Key Growth Drivers Over the Next 3 Years...
Mercer Capital's Value Focus: Healthcare Facilities | Mid-Year 2016 |Mercer Capital
Mercer Capital's Healthcare Facilities Industry newsletter provides perspective on valuation issues. Each newsletter also includes macroeconomic trends, industry trends, and guideline public company metrics.
Similar to Medical Facilities Corporation - Investor Update - March 2020 (20)
A look at D-BOX's 2023 third quarter results and exciting developments in the sim racing market --- F1 Arcade rollout + collaborations with Trak Racer, RSEAT, and Mercedes.
During the quarter, Kindred Concepts opened its first F1 Arcade location in London, England. This state-of-the art F1 racing simulation center features 60 D-BOX-equipped simulators. Kindred Concepts has plans for opening 30 D-BOX-equipped F1 Arcade locations over the next five years.
Precision Biomonitoring - TSX Life Science Day - February 2021SharePitch
Precision Biomonitoring is a private company based in Guelph, Ontario. We are at the forefront of rapid onsite DNA-based surveillance and detection, including polymerase chain reaction, or PCR, tests, such as those used to detect COVID-19 and other infectious diseases. Our key differentiator is that our solutions provide faster, more reliable test results – anytime, anywhere – and we are able to achieve this differentiation thanks to our proprietary TripleLock technology platform.
Ceres Global Ag - Annual Meeting Presentation - November 12, 2020SharePitch
An ovevriew of the business and strategy of Ceres Global Ag, presented during their annual general meeting of shareholders on November 12, 2020.
Through its network of commodity logistics centers and team of industry experts, Ceres Global merchandizes high-quality North American agricultural commodities and value-added products and provides reliable supply chain logistics services to agricultural, energy and industrial customers worldwide.
Ceres Global is headquartered in Minneapolis, Minnesota, and together with its affiliated companies, operates 13 locations across Saskatchewan, Manitoba, Ontario, and Minnesota. These facilities have an aggregate grain and oilseed storage capacity of approximately 31 million bushels.
For more information about Ceres Global, please visit www.ceresglobalagcorp.com
Medical Facilities Corporation - 2019 Annual ReportSharePitch
MFC remains well aligned for one of the major trends in U.S. healthcare, which has been the growing number of
surgical procedures that are being performed in outpatient settings. Additionally, the demand for health care services
continues to grow, as a result of a growing and aging population, as well as increasing in breadth and scope of
procedures, such as knee replacement surgery.
View the full HTML version of the report at https://2019ar.medicalfacilitiescorp.ca/wp-content/uploads/2020/04/MFC-2019-Print-Annual-2020-04-03a.pdf
Medical Facilities' common shares trade on the TSX under the symbol DR.
Flower One Holdings - Investor Presentation - April 2020SharePitch
Flower One is the largest cannabis cultivator, producer, and full-service brand fulfillment partner in the state of Nevada. The Company's common shares are traded on the Canadian Securities Exchange under the Company's symbol "FONE", in the United States on the OTCQX Best Market under the symbol "FLOOF" and on the Frankfurt Stock Exchange under the symbol "F11". For more information, visit: https://flowerone.com.
Centric Health Corporation - Investor Presentation - April 2020SharePitch
Centric Health is an essential services provider and one of Canada's leading providers of Specialty Pharmacy services to seniors in long-term care and retirement homes. Centric Health's common shares are listed on the TSX under the symbol CHH.
Cleades Robinson, a respected leader in Philadelphia's police force, is known for his diplomatic and tactful approach, fostering a strong community rapport.
Methanex is the world's largest producer and supplier of methanol. We create value through our leadership in the global production, marketing and delivery of methanol to customers. View our latest Investor Presentation for more details.
UnityNet World Environment Day Abraham Project 2024 Press ReleaseLHelferty
June 12, 2024 UnityNet International (#UNI) World Environment Day Abraham Project 2024 Press Release from Markham / Mississauga, Ontario in the, Greater Tkaronto Bioregion, Canada in the North American Great Lakes Watersheds of North America (Turtle Island).
ZKsync airdrop of 3.6 billion ZK tokens is scheduled by ZKsync for next week.pdfSOFTTECHHUB
The world of blockchain and decentralized technologies is about to witness a groundbreaking event. ZKsync, the pioneering Ethereum Layer 2 network, has announced the highly anticipated airdrop of its native token, ZK. This move marks a significant milestone in the protocol's journey, empowering the community to take the reins and shape the future of this revolutionary ecosystem.
World economy charts case study presented by a Big 4
World economy charts case study presented by a Big 4
World economy charts case
World economy charts case study presented by a Big 4
World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4
World economy charts case study presented by a Big 4
World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4study presented by a Big 4
2. Forward-Looking Statements
This presentation may contain forward-looking statements within the meaning of certain securities laws,
including the “safe harbour” provisions of the Securities Act (Ontario) and other provincial securities law in
Canada. These forward-looking statements include, among others, statements with respect to our objectives,
goals and strategies to achieve those objectives and goals, as well as statements with respect to our beliefs,
plans, objectives, expectations, anticipations, estimates and intentions. The words “may”, “will”, “could”,
“should”, “would”, “suspect”, “outlook”, “believe”, “plan”, “anticipate”, “estimate”, “expect”, “intend”, “forecast”,
“objective” and “continue” (or the negative thereof), and words and expressions of similar import, are intended
to identify forward-looking statements. Any such statements are subject to risks and uncertainties that could
cause actual results to differ materially from those projected in these forward-looking statements. For more
information on the risk factors related to these forward-looking statements, please refer to the management’s
discussion and analysis, annual information form and ongoing quarterly filings of Medical Facilities Corporation
available on SEDAR at www.sedar.com.
2
3. MFC Overview
US$398.1
million
2019 Revenue*
US$96.2
million
2019 Adj. EBITDA*
189
Physician Partners**
US$44.5
million
2019 Income from
Operations*
• HIGHER PATIENT
SATISFACTION ratings
resulting from HIGHER
QUALITY OF CARE
• DIRECT PHYSICIAN
INVOLVEMENT in
facility management,
resulting in SUPERIOR
PROCESSES AND
EFFICIENCIES
* Figures have been modified to reflect continuing operations only, which is defined as
consolidated operations excluding Unity Medical and Surgical Hospital and RRI Mishawaka
Hospital, LP. These entities are treated as discontinued operations in the financial results for
the fourth quarter and year ended December 31, 2019.
** As at December 31, 2019.
4. Strategic Guiding Principles
MFC delivers value from a strong foundation of high-quality facilities providing
exceptional patient care while exercising prudent financial management that has
resulted in a long track record of solid returns.
Industry leading quality
and service
Focused on maximizing
operating efficiencies
Organic and acquisition
growth strategies
Strong physician-centric
management model
4
5. Diverse High Quality Portfolio
Specialty Surgical Hospitals
Ambulatory Surgery Centers
• 11 facilities in 10 states
• 62 operating rooms
• 127 overnight beds
• 11 procedure rooms
• 6 urgent care clinics
5
6. Strong Payor Mix
51%
34%
15%
Private Insurance Medicare/Medicaid Other
38%
34%
28%
Private Insurance Medicare/Medicaid Other
Source: Centers for Medicare & Medicaid Services, National Health Expenditure Projections
2019 MFC Facility Service Revenue 2019 U.S. Healthcare System Revenue
6
7. Growing Demand for Healthcare
0
15
30
45
60
75
2015 Today 2020 2025 2030
U.S. population aged 65+ (millions)
Drivers:
• Overall population growth
• Aging population
Source: Census.gov 7
8. The U.S. Healthcare Landscape
Facility type Number Services MFC’s position
Acute Care Hospital Approx. 5,500
General medicine and
surgery, including emergency
and maternity care, open
24/7
Specialty Surgical Hospital <300 physician-owned
Scheduled elective
procedures (e.g. orthopedics,
neurosurgery, pain
management)
Owns 4 in conjunction with
physician partners
Ambulatory Surgery Center Approx. 5,500
Scheduled elective
procedures;
Day surgery only
Owns 7 in conjunction with
physician partners
8
9. Focused on Growth
9
Expand capacity of
existing facilities
Diversify our revenue
base
Leverage our MFC
Nueterra Partnership
• Recruit new physicians
• Enhance facilities and
equipment through capital
investment
• Add ancillary services
• i.e. urgent care clinics
• Establishes a platform for
growth that facilitates future
acquisitions
10. Disciplined Approach to Acquisitions
Strict
acquisition
criteria
Accretion, with growth available from a strong
provider base and opportunities for operating
enhancements
High quality and optimum clinical outcomes
Continued strong earnings and
opportunity for growth
1
2
3
10
11. Operating Results – Q4 2019
1
1 Adjusted EBITDA, cash distributions and payout ratio are non-IFRS financial measures. Please refer to “Non-IFRS Financial Measures” and “Reconciliation of Non-IFRS Financial Measures”
sections in the Management’s Discussion and Analysis.
2 Adjusted for goodwill impairment of $22.0M in Q3’19.
3 Figures have been modified to reflect continuing operations only, which is defined as consolidated operations excluding Unity Medical and Surgical Hospital and RRI Mishawaka Hospital, LP.
These entities are treated as discontinued operations in the financial results for the fourth quarter and year ended December 31, 2019.
(US$ millions, except where noted otherwise) Q4 2019 Q4 2018
Change
%
FY2019 FY2018
Change
%
REVENUE3 114.0 112.0 1.8% 398.1 390.8 1.9%
INCOME FROM OPERATIONS3 25.9 23.8 8.8% 44.5 72.5 (38.7%)
ADJUSTED EBITDA2,3 32.7 30.1 8.5% 96.2 93.4 3.1%
ADJUSTED EBITDA MARGIN2,3 28.7% 26.9% 6.7% 24.2% 23.9% 1.3%
CASH DISTRIBUTIONS
(C$ MILLIONS)
4.4 8.7 (50.0%) 30.6 34.9 (12.3%)
PAYOUT RATIO 37.0% 46.2% (19.9%) 111.1% 71.4% 55.6%
11
12. Well Resourced for Continued Growth
$32.0
million
Cash& Short-term
Investments
1.08
Net Debt* /
Equity
1.94
Net Debt* /
Adj. EBITDA (LTM)
1.8x
Current Ratio
As at December 31, 2019 12
* inclusive of lease liabilities per IFRS 16
13. Management Team
David N.T. Watson
Chief Financial Officer
Formerly: Clearway Pain Solutions,
National Surgical Hospitals
Robert O. Horrar
President and Chief Executive Officer
Formerly: Community Health Systems, Humana
James D. Rolfe
Chief Development Officer
Formerly: VMG Health, Community Health Systems
John Schario
Chief Operating Officer
Formerly: Nueterra Healthcare Management,
Mountain States Health Alliance
13
14. Investment Highlights
• Large, growing & fragmented market for outpatient
services
• Diverse portfolio of highly rated, high quality facilities
• Scalable platform for growth – organically and via
acquisitions
• Experienced, entrepreneurial management team
• Competitive dividend
15. Capital Markets Profile
As at February 28, 2020
15
Stock Symbol: TSX: DR
Shares Outstanding: 31.1 million
Price: $3.16
Market Capitalization: $98.30 million
Annualized Distribution (per share): $0.28
Current Yield: 8.86%
*All figures in Canadian dollars
16. To learn more, contact
Trevor Heisler
NATIONAL Capital Markets
416-848-1434
theisler@national.ca